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A brief mcubatlon of lymphocytes with either PMA. stimulatmg protein kinase C, or with dlbutyryl-CAMP. leadmg to protein kinase A activation, 
led to Increased lymphocyte penetration through Intact endothehal monolayers in vitro The PMA-Induced penetration could be dose-dependently 
down-regulated with a protem kinase C inhibitor. H7. Similarly HA 1004, bemg mainly a protein kinase A Inhibitor. decreased the dibutyryl-CAMP 
Induced penetration. Treatment of lymphocytes with PMA and CAMP did not alter the expression of CD44 hommg receptors on lymphocytes 
Stimulation of lymphocytes with dibutyryl-cGMP or calcium ionophore had no effect on lymphocyte penetration These results suggest that activa- 
tion of both protem kmases A and C IS important m the lymphocyte bmding to endothelium. 
Protem kmase A. Protem kmase C: Endothehal cell 
1. INTRODUCTION 
Recirculating lymphocytes exit the blood circulation 
via specialized high endothelial venules (HEV) lined by 
a typical high endothelium (HE) [ 11. Lymphocytes have 
homing receptors on their surface. In mice MEL-14 
defines a receptor responsible for lymphocyte homing 
into peripheral lymph nodes and LPAM-1 a receptor 
responsible for homing into Peyer’s patches [2,3]. On 
the endothelial side specific vascular addressins 
recognize these homing receptors [4]. Besides these 
organ- and/or tissue-specific receptor-ligand pairs also 
non-specific mechanisms exist. Lymphocyte function 
antigens (LFA-l), which belong to the integrin family, 
are the counterpart for ICAM- and ICAM- on en- 
dothelial cells [5,6]. Besides strengthening the adhe- 
sion, the interaction between LFA-1 and ICAM- 
provides an additional intracellular signal [7,8]. 
penetration through endothelial monolayers. It is 
demonstrated in this paper that treatment of lym- 
phocytes with a protein kinase C pathway stimulator, 
PMA, and protein kinase A stimulator, dibutyryl- 
cAMP, lead to rapid increase in the number of lym- 
phocytes penetrating through endothelial layer. This 
penetration event was dose-dependent, and it was 
possible to inhibit it by relevant PKC or PKA in- 
hibitors. The rapid activation of protein kinases and in- 
duction of lymphocyte penetration did not correlate to 
increased expression of lymphocyte homing receptor 
Hermes-3. 
2. MATERIALS AND METHODS 
12.1 Ceils 
Activation of in vitro cultured endothelial cells by 
several cytokines and lipid mediators leads to increased 
binding of lymphocytes to endothelial monolayers 
[9-131. For instance, IL-la operates via CAMP in the 
induction of binding to endothelial monolayers [14]. 
Similarly all these cytokines also increase the penetra- 
tion on lymphocytes through the endothelium [ 15,161. 
Our recent results indicate that the signal transduction 
pathway during IL-l stimulation in the binding phase 
is similar to the penetration phase [16]. 
Human umbilical kein endothelial cell-line EA.hy 926 was obtained 
from Dr C.-J.S. Edge11 (University of North Carolina, NC, USA) 
[17]. Peripheral blood leukocytes were isolated with a density gra- 
dient centrifugation (Ficoll-Isopaque. Nycomed, Norway) in a 
routine manner. Adherent monocytes were depleted by two con- 
secutive 1 h incubations in plastic Petri dishes and the remaining 
loose cells were used m the lymphocyte penetration assay. 
2.2. Penetration assay 
Much less is known about the activation status of 
lymphocytes in correlation to their binding to and 
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0.4 x 10h endothelial cells were seeded on a Millipore falter (Sar- 
torius, Vangard Int., NJ) placed under a glass O-ring (dtameter 
15 mm) m a 24-macrowell tissue culture plate (Nunclon). After an 
overnight incubation, the EC were growing as a tight monolayer. The 
cultures were washed with warm media and 2 x lo6 lymphocytes were 
placed on top of the EC layers into the glass O-rings. After a 3 h in- 
cubation at 37”C, the media on top of the filter were removed. The 
filters were then washed, fixed in 70% ethanol overmght and stained 
with Mayer’s hemalun. From these preparations it was posstble to 
determine separately the leukocytes remaming on top of the EC- 
monolayer, and the number of cells which were under the monolayer 
and had penetrated through the endothelial monolayer into the filter. 
The number of penetrated lymphocytes was calculated from at least 
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20 mdtwdual high power ftelds and figures are grven as number of 
cells penetrated/ 1 mm’ of endothehal monolayer. The endothehal 
monolayer war bertfled by ordinary hght microscopy and cross- 
section preparattons m the electron mrcroscop). 
2.3. Reagents 
Monoclonal Hermes-3 antibody detectmg CD-U uas obtarned as a 
generous gtft from Sirpa Jalkanen (Umversity of Turku, FInland). 
Sttmulators of rntracellular srgnal transductron: NG.2 ’ -0. 
dibutyryladenosme 3’,5’-cyclic monophosphate (cAMPI, ,‘v’2,2’-O- 
dibutyrylguanosine 3’.5’-cyclic monophosphate (cGMP), calctum 
ionophore A23187 and phorbol 12.myrrstate 13.acetate (PMA) were 
all purchased from Srgma In some experiments the lymphocytes \\ere 
treated with second messenger sttmulators in combmation with pro- 
tein kinase C inhrbrtor I-(5.isoqumolrnesulfonyl)-?-methylptperazine 
dthydrochlorrde (H7), wrth a cyclrc nucleotrde protem kinase (A) n- 
htbttor HA1004 Both enzyme rnhtbttors were purchased from 
Seikagaku Kogyo (Tokyo, Japan). 
3. RESULTS 
In the first set of experiments I first isolated lym- 
phocytes from peripheral blood white cells. These lym- 
phocytes were then incubated with various activators of 
intracellular second messengers prior to adding the 
lymphocytes to endothelial monolayer-coated Millipore 
filters. After a 3 h incubation, the loose lymphocytes 
were washed away, the Millipore filters were fixed with 
70% ethanol and stained with Mayer’s hemalun. From 
these preparations it was possible to determine the 
number of lymphocytes that had penetrated through 
the endothelial monolayer into the filter. 
Previous work had shown that 30 min pretreatment 
of lymphocytes with PMA, which is a protein kinase C 
stimulator, increased the number of lymphocytes 
homoaggregations as well as binding to in vitro 
cultured endothelial cells [18]. Lymphocytes were in- 
cubated for 30 min with PMA (1 .O ELM) prior to the 
penetration assay. PMA pretreatment increased the 
number of penetrated lymphocytes from 1009 ? 241 to 
4865 f 801 per mm* of endothelial monolayer (P < 
0.001. Fig. 1). Also dibutyryl-CAMP, an analogue of 
CAMP able to penetrate into the cell, increased lym- 
phocyte penetration up to 2399 ? 614 cells per mm’ (P 
< 0.01). On the other hand, ditubyryl-cGMP, increas- 
ing the intracellular levels of cGMP, as well as the 
calcium ionophore (A23187), increasing intracellular 
Ca2+ concentrations, had no effect after 30 min prein- 
cubation on the number of lymphocytes that had 
penetrated through endothelial monolayers into the 
Millipore filter. 
Further evidence of the role of activation of protein 
kinase C in the lymphocyte penetration came from the 
enzyme inhibition studies. An inhibitor to protein 
kinase C, H7 had a clear dose-dependent effect on the 
PMA-induced lymphocyte penetration. A 2 PM dose of 
H7 had no effect on the PMA-induced penetration; 
10 PM H7 already decreased the number of penetrating 
lymphocyte from 4865 f 801 to 2710 i: 437 correspon- 
ding to a 56% decrease of the * PMA induced increase. 
90 
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Ftg. 1. Regulatton of lymphocyte penetratton through intact 
endothehal monolayers I.ymphocytes wete attmulated with various 
actrvatort of second messengers for 30 min. washed and placed on 
the endotheltal layer growing on a hlrllrpore falter in a cylinder. After 
3 h mcubatron. the filters were \vashed. fryed and stamed. From these 
preparations it was posstble to determrne the number of lymphocytes 
penetratrng through endothelial cells Into the filter. The data are 
cypressed as number of penetrated lymphocytes per 1 mm’ of 
sndothelial layer. Rlean t SD of 7 Independent e\perrment\ P-values 
are calculated according to patred Student’s r-test: * P < 0.05; 
** P < 0.01: and *** P < 0.001. 
Finally 20 FM of H7 decreased up to 93Vo of the lym- 
phocyte penetration (Fig. 2). 
Similarly HA 1004 is an inhibitor of protein kinase 
A. HA 1004 could dose-dependently decrease 
dibutyryl-CAMP induced lymphocyte penetration. The 
maximal effect was seen at a dose of 20/M of 
HA 1004, when 61vo of the dibutyryl-CAMP induced 
increase in lymphocyte penetration was inhibited 
(Fig. 3). 
Hermes-3 (CD44) is an antibody against a lym- 
phocyte homing receptor. In my assay the 30 min in- 
cubation with PMA or dibutyryl-CAMP had no effect 
on the number of Hermes-3-positive lymphocytes or on 
lOuM( /-i ** 
2ouM 
*** 
, .I . I . I . I 
0 1ooO20003ooo4ooo5fMO~ 
Penetrated lymphocytedmm 2 
Fig. 2. The role of H7, a protem kmase C inhtbitor, on PMA-induced 
lymphocyte penetratton. The lymphocytes were treated with PMA as 
in Fig. 1. In addrtion, H7 \has added simultaneously uith PMA Into 
the indicated samples. H7 had a clear dose-dependent abtlity to 
decrease the PhlA-Induced penetratton. hlean t SD of 7 Independent 
experiments For P-values we legend to Frg 1. 
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Ftg. 3. The role of HA 1004, a protein kinase A inhibitor, on 
dibutyryl-CAMP-induced lymphocyte penetration. HA 1004 could 
partially inhibtt the induced penetration in a dose-dependent manner. 
Mean + SD of 7 independent experiments. For P-values see legend 
to Fig. 1. 
the amount of CD 44 on the individual lymphocytes 
when tested with flow cytometry and compared to non- 
treated iymphocytes (data not shown). 
4. DISCUSSION 
The local inflammation process is characterized by 
an influx of white cells in situ. The regulatory role of 
endothelial cells has become evident in the initiation of 
the inflammation process. The white cells bear homing 
receptors on their surface which recognize their 
counterpart, vascular addressins on the endothelial 
side. Only a very small proportion of white cells bound 
to endothelium will penetrate through it [ 191. Therefore 
the binding to endothelial cells is a necessary but not 
the only step in white cell invasion from bIood circula- 
tion to sites of inflammation. 
Previous work with PMA had shown that it 
stimulates protein kinase C in many cell types, like in 
normal white cells, hematopoietic tumor cells and in 
endothelial cells [20,21]. Concomitantly PMA induces 
many cell types to adhere onto plastic surfaces, to each 
other and to endothelial monolayers [18]. Therefore I 
asked the question, does increased adherence lead to in- 
creased penetration through endothelial monolayers? 
We had previously described a reliable technique for 
analysing the lymphocyte penetration through en- 
dothelial monolayers. The endothehal cells were 
cultured in a cylinder placed upon a Millipore filter and 
after the endothelial cells had formed a tight monolayer 
in the cylinder, the tested lymphocytes were placed on 
top of the endothelial layer in the cylinder [ 131. After 
a 3 h incubation period, the filters were washed, fixed 
and stained. In this model it was possible to analyse the 
role of protein kinase A and C in the lymphocyte 
penetration. 
Stimulation of lymphocytes either alone with PMA 
or with dibutyryl-CAMP increased the number of lym- 
phocytes penetrating through endothelial monolayers. 
IFN-y has been shown to activate protein kinase C and 
calcium fluxes in many cells like endothelial cells. Even 
though the activation of PKC occurs very rapidly 
(within lo-15 min) in the endothehal cells after IFN-y 
treatment 1221, IFN-y itself requires several hours of in- 
cubation before it increases lymphocyte penetration 
through endothelial cells. 
IL-l-induced lymphocyte binding to and penetration 
through endothelial monolayers has been linked to 
CAMP as a second messenger. IL-1 stimulation in- 
creases within 10 min the intracellular CAMP levels, 
and forskolin, which is an activator of adenylate 
cyclase, can mimick IL-l effects 1141. Dideox- 
yadenosine, an adenylate cyclase inhibitor, can almost 
totally inhibit IL-l-induced in vitro lymphocyte homing 
as well as increasing intracellular cAMP levels, and 
finally IL-1 leads to activation of protein kinase A in a 
phosphorylation assay. 
IL-l also requires several hours of incubation with 
endothelial cells before it increases the lymphocyte bin- 
ding and penetration. Already a 30 min incubation of 
lymphocytes with dibutyryl-CAMP led to a significant 
increase in lymphocyte penetration. The role of the 
dibutyryl compound to cause this effect can be ruled 
out due to the fact that dibutyryl-cGMP was totally in- 
effective in the penetration assay. 
Taken together, these results show that stimmation 
of lymphocyte protein kinase A and C can lead to a 
rapid increase in the number of lymphocytes 
penetrating through endothelial monolayers. 
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